Rivastigmine in the treatment of Sleep REM Behaviour Disorder (RBD) and Hallucinations in Parkinsonism: a Clinical and Polysomnographic study’

Registry ID

EUCTR2009-012071-10

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Start date

2009-06-15

Last update

2026-08-16

Conditions

• PARKINSONISM

Summary

evaluate the efficacy of the Cholinesterase Inhibitor treatment in Parkinson’s disease patients with hallucinations and RBD non-responders to Antipsychotic and Clonazepam therapy

Locations

• , , Italy

View on source registry